Literature DB >> 19468724

Association of body mass index and urine pH in patients with urolithiasis.

Wei-Ming Li1, Yii-Her Chou, Ching-Chia Li, Chia-Chu Liu, Shu-Pin Huang, Wen-Jeng Wu, Chi-Wen Chen, Chien-Yu Su, Mei-Hui Lee, Yu-Ching Wei, Chun-Hsiung Huang.   

Abstract

Increase in body size increases the risk of renal stone formation. The mechanism explaining this relationship remains unclear. Urine pH is one of the important factors for urinary stone formation. The purpose of this study was to determine whether there is an association between urine pH and body mass index (BMI) in patients with urolithiasis. Medical charts review that included 342 urinary stone formers (248 men and 94 women). Data obtained included patient sex, age, BMI, urine pH at diagnosis, and stone composition. The patients were classified as normal weight (18.5 <or= BMI < 24), overweight (24 <or= BMI < 27), or obese (BMI >or= 27). The mean urine pH of the normal body weight, overweight, and obese groups was 6.25, 6.14, and 6.00, respectively (P < 0.05). Urine pH is inversely related to BMI among patients with urolithiasis. Among patients with urolithiasis, higher BMI will have lower urine pH. This may explain why obesity is associated with an increased risk of nephrolithiasis. Weight loss should be explored as a potential treatment to prevent kidney stone formation. The prevention of urinary stone disease gives clinicians an additional reason to encourage weight reduction through diet.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468724     DOI: 10.1007/s00240-009-0194-4

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  21 in total

1.  Studies on the pathophysiology of the low urine pH in patients with uric acid stones.

Authors:  Kamel S Kamel; Surinder Cheema-Dhadli; Mitchell L Halperin
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

2.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

3.  National trend of the incidence of urolithiasis in Japan from 1965 to 1995.

Authors:  O Yoshida; A Terai; T Ohkawa; Y Okada
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

4.  Type 2 diabetes increases the risk for uric acid stones.

Authors:  Michel Daudon; Olivier Traxer; Pierre Conort; Bernard Lacour; Paul Jungers
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

5.  Insulin stimulates ammoniagenesis in canine renal proximal tubular segments.

Authors:  M C Chobanian; M R Hammerman
Journal:  Am J Physiol       Date:  1987-12

6.  Obesity, weight gain, and the risk of kidney stones.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

7.  Insulin activates Na(+)/H(+) exchanger 3: biphasic response and glucocorticoid dependence.

Authors:  Jelena Klisic; Ming Chang Hu; Vera Nief; Livia Reyes; Daniel Fuster; Orson W Moe; Patrice M Ambühl
Journal:  Am J Physiol Renal Physiol       Date:  2002-09

8.  Association of urinary pH with body weight in nephrolithiasis.

Authors:  Naim M Maalouf; Khashayar Sakhaee; Joan H Parks; Frederic L Coe; Beverley Adams-Huet; Charles Y C Pak
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

9.  Renal stone epidemiology: a 25-year study in Rochester, Minnesota.

Authors:  C M Johnson; D M Wilson; W M O'Fallon; R S Malek; L T Kurland
Journal:  Kidney Int       Date:  1979-11       Impact factor: 10.612

10.  Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

Authors:  F L Levy; B Adams-Huet; C Y Pak
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

View more
  23 in total

1.  Obesity and Its Impact on Kidney Stone Formation.

Authors:  William Poore; Carter J Boyd; Nikhi P Singh; Kyle Wood; Barbara Gower; Dean G Assimos
Journal:  Rev Urol       Date:  2020

Review 2.  Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanisms.

Authors:  Ozgu Aydogdu
Journal:  World J Nephrol       Date:  2012-02-06

3.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 4.  Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.

Authors:  Aslam Khan
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

5.  Body fat composition and occurrence of kidney stones in hypercalciuric children.

Authors:  Rose Ayoob; Wei Wang; Andrew Schwaderer
Journal:  Pediatr Nephrol       Date:  2011-06-10       Impact factor: 3.714

6.  Difference in urinary stone components between obese and non-obese patients.

Authors:  Yii-Her Chou; Ching-Ming Su; Ching-Chia Li; Chia-Chu Liu; Mu-En Liu; Wen-Jeng Wu; Yung-Shun Juan
Journal:  Urol Res       Date:  2010-12-16

7.  A population-based study on the association between urinary calculi and kidney cancer.

Authors:  Shiu-Dong Chung; Shih-Ping Liu; Herng-Ching Lin
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

8.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

9.  Association Between Adiponectin and Insulin Resistance in Diabetic Urolithiasis.

Authors:  Dona Devasia; Kavitha Meiyappan; Palani Selvam Mohanraj; Dorairajan Lalgudi Narayanan; Gandhipuram Periyasamy Senthilkumar; Md Yasir
Journal:  Oman Med J       Date:  2017-03

10.  Association of urolithiasis with systemic conditions among pediatric patients at children's hospitals.

Authors:  Paul J Kokorowski; Jonathan C Routh; Katherine C Hubert; Dionne A Graham; Caleb P Nelson
Journal:  J Urol       Date:  2012-08-18       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.